Sam Altman Moves to Dismiss Punitive Damages in Sister's Sexual Abuse Lawsuit 
Federal Judge Dismisses DOJ Lawsuit Attempting to Block Hawaii's Climate Case Against Oil Giants 
Texas AG Investigates Lululemon Over "Forever Chemicals" in Activewear 
Japan to Subsidize Sony's Image Sensor Plant in Kumamoto with $380 Million 
Samsung Races to Deliver Next-Gen HBM4E Memory Samples to Nvidia 
NiSource Signs Long-Term Energy Deals with Alphabet and Amazon to Power Indiana Data Centers 
CSN's Cement Unit Sale Could Exceed $2 Billion as Global Giants Circle 
Iran War Drives Asia's Plastic Crisis — and a Green Packaging Boom 
CATL Stock Hits Record High After Q1 2025 Earnings Surge 
Uber Bets Big on Autonomous Vehicles with $10 Billion Commitment 
ASML Raises 2026 Revenue Outlook as AI Chip Demand Surges 
SK Hynix Shares Hit Record High Amid AI Memory Demand Surge 
Pentagon Taps Auto Giants to Supercharge U.S. Weapons Production 
Amazon in Advanced Talks to Acquire Globalstar in Starlink Rivalry Move 
Qantas Raises Fuel Cost Forecast Amid Middle East Oil Crisis 
Netflix Q2 Profit Warning Sends Shares Tumbling as Reed Hastings Exits 
OpenAI's $20 Billion Cerebras Deal Signals Massive AI Infrastructure Push 
MINNEAPOLIS, May 31, 2017 -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq:TCMD), a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency, today announced that management will participate in the William Blair Growth Stock Conference at the Four Seasons Hotel in Chicago, Illinois. Management will host a presentation with investors on Tuesday, June 13, at 12:10 pm Central Time.
A live audio webcast of the presentation will be accessible under the “Events & Webcasts” section of the Company's investor relations website at http://investors.tactilemedical.com. An archive of the webcast will be available for replay following the conference.
About Tactile Medical
Tactile Medical is a leader in developing and marketing at-home therapy devices for the treatment of lymphedema and chronic venous insufficiency. Our unique offering includes advanced, clinically proven pneumatic compression devices, as well as continuity of care services provided by a national network of product specialists and trainers, reimbursement experts, patient advocates and clinicians. This combination of products and services ensures that tens of thousands of patients annually receive the at-home treatment necessary to better manage their chronic conditions. Tactile Medical takes pride in the fact that our solutions help increase clinical efficacy, reduce overall healthcare costs and improve the quality of life for patients with chronic conditions.
Investor Inquiries: Mike Piccinino, CFA Managing Director Westwicke Partners 443-213-0500 [email protected]
